Caption Management, LLC Amylyx Pharmaceuticals, Inc. Put Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$2.71 - $19.57 $406,500 - $2.94 Million	150,000 New	150,000 $426,000
Q3 2023 Nov 14, 2023	BUY	$18.08 - $23.45 $972,703 - $1.26 Million	53,800 Added 30.92%	227,800 $4.17 Million
Q2 2023 Aug 14, 2023	BUY	$20.98 - $31.42 $3.34 Million - $5 Million	159,000 Added 1060.0%	174,000 $3.75 Million
Q1 2023 May 15, 2023	BUY	$27.71 - $40.93 $415,650 - $613,950	15,000 New	15,000 $440,000
Q3 2022 Nov 14, 2022	BUY	$17.15 - $30.92 $1.63 Million - $2.94 Million	95,000 Added 190.0%	145,000 $4.08 Million
Q2 2022 Aug 15, 2022	BUY	$6.85 - $19.93 $342,500 - $996,500	50,000 New	50,000 $963,000

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $237M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.